BACKGROUND: Previous studies in glioblastoma have concluded that there is no decrease in survival with increasing time to initiation of RT up to 6 weeks after surgery. Unfortunately, the number of glioblastoma patients who start RT beyond 6 weeks is not small in some countries. The aim of our study was to evaluate the effect of RT delay beyond 6 weeks on survival of patients who have undergone completed resection of a glioblastoma. METHODS: We reviewed 107 consecutive glioblastoma patients who had a complete surgical resection at our hospital. Clinical data, including delay in initiation of RT, were prospectively collected. The impact of single parameters on overall survival was determined by univariate and multivariate analyses. RESULTS: According to univariate analysis, variables that had a prognostic influence on survival were age (p = 0.036), KPS (p = 0.031), additional treatment with CHT (p < 0.0001), and initiation of RT before 42 days (p = 0.009). Multivariate analysis indicated that Karnofsky performance scale, additional treatment with chemotherapy, and initiation of RT before 6 weeks after surgery were favorable, independent prognostic factors of survival. CONCLUSIONS: Survival is significantly reduced in glioblastoma patients if RT is not initiated within the 6 weeks after complete resection of the tumor.
BACKGROUND: Previous studies in glioblastoma have concluded that there is no decrease in survival with increasing time to initiation of RT up to 6 weeks after surgery. Unfortunately, the number of glioblastomapatients who start RT beyond 6 weeks is not small in some countries. The aim of our study was to evaluate the effect of RT delay beyond 6 weeks on survival of patients who have undergone completed resection of a glioblastoma. METHODS: We reviewed 107 consecutive glioblastomapatients who had a complete surgical resection at our hospital. Clinical data, including delay in initiation of RT, were prospectively collected. The impact of single parameters on overall survival was determined by univariate and multivariate analyses. RESULTS: According to univariate analysis, variables that had a prognostic influence on survival were age (p = 0.036), KPS (p = 0.031), additional treatment with CHT (p < 0.0001), and initiation of RT before 42 days (p = 0.009). Multivariate analysis indicated that Karnofsky performance scale, additional treatment with chemotherapy, and initiation of RT before 6 weeks after surgery were favorable, independent prognostic factors of survival. CONCLUSIONS: Survival is significantly reduced in glioblastomapatients if RT is not initiated within the 6 weeks after complete resection of the tumor.
Authors: Yaacov Richard Lawrence; Deborah T Blumenthal; Diana Matceyevsky; Andrew A Kanner; Felix Bokstein; Benjamin W Corn Journal: J Neurooncol Date: 2011-04-24 Impact factor: 4.130
Authors: Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee Journal: J Neuropathol Exp Neurol Date: 2002-03 Impact factor: 3.685
Authors: M D Walker; E Alexander; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; H A Norrell; G Owens; J Ransohoff; C B Wilson; E A Gehan; T A Strike Journal: J Neurosurg Date: 1978-09 Impact factor: 5.115
Authors: N Murray; P Coy; J L Pater; I Hodson; A Arnold; B C Zee; D Payne; E C Kostashuk; W K Evans; P Dixon Journal: J Clin Oncol Date: 1993-02 Impact factor: 44.544
Authors: C Majós; M Cos; S Castañer; A Pons; M Gil; A Fernández-Coello; M Macià; J Bruna; C Aguilera Journal: AJNR Am J Neuroradiol Date: 2016-09-08 Impact factor: 3.825
Authors: C Balaña; A Estival; I Teruel; M Hardy-Werbin; J Sepulveda; E Pineda; M Martinez-García; O Gallego; R Luque; M Gil-Gil; C Mesia; S Del Barco; A Herrero; A Berrocal; P Perez-Segura; R De Las Penas; J Marruecos; R Fuentes; G Reynes; J M Velarde; A Cardona; E Verger; C Panciroli; S Villà Journal: Clin Transl Oncol Date: 2018-05-08 Impact factor: 3.405
Authors: Daniel E Spratt; Michael Folkert; Zachary S Zumsteg; Timothy A Chan; Kathryn Beal; Philip H Gutin; Elena Pentsova; Yoshiya Yamada Journal: J Neurooncol Date: 2013-11-05 Impact factor: 4.130
Authors: Erqi L Pollom; Dylann K Fujimoto; Summer S Han; Jeremy P Harris; Suzanne A Tharin; Scott G Soltys Journal: J Radiat Res Date: 2018-03-01 Impact factor: 2.724
Authors: Ruichong Ma; Aswin Chari; Paul M Brennan; Andrew Alalade; Ian Anderson; Anna Solth; Hani J Marcus; Colin Watts Journal: Neurooncol Pract Date: 2017-09-27
Authors: Amedeo A Azizi; Simon Paur; Alexandra Kaider; Karin Dieckmann; Andreas Peyrl; Monika Chocholous; Thomas Czech; Irene Slavc Journal: Strahlenther Onkol Date: 2018-01-18 Impact factor: 3.621